Does CABOTEGRAVIR\RILPIVIRINE Cause Off label use? 366 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 366 reports of Off label use have been filed in association with CABOTEGRAVIR\RILPIVIRINE. This represents 7.3% of all adverse event reports for CABOTEGRAVIR\RILPIVIRINE.
366
Reports of Off label use with CABOTEGRAVIR\RILPIVIRINE
7.3%
of all CABOTEGRAVIR\RILPIVIRINE reports
1
Deaths
2
Hospitalizations
How Dangerous Is Off label use From CABOTEGRAVIR\RILPIVIRINE?
Of the 366 reports, 1 (0.3%) resulted in death, 2 (0.5%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOTEGRAVIR\RILPIVIRINE. However, 366 reports have been filed with the FAERS database.
What Other Side Effects Does CABOTEGRAVIR\RILPIVIRINE Cause?
Product dose omission issue (655)
Injection site pain (545)
Viral load increased (428)
Pain (256)
Virologic failure (255)
Product use in unapproved therapeutic environment (239)
Pathogen resistance (202)
Product storage error (168)
Inappropriate schedule of product administration (162)
Product complaint (158)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CABOTEGRAVIR\RILPIVIRINE Alternatives Have Lower Off label use Risk?
CABOTEGRAVIR\RILPIVIRINE vs CABOZANTINIB
CABOTEGRAVIR\RILPIVIRINE vs CABOZANTINIB S-MALATE
CABOTEGRAVIR\RILPIVIRINE vs CAFFEINE
CABOTEGRAVIR\RILPIVIRINE vs CALASPARGASE PEGOL
CABOTEGRAVIR\RILPIVIRINE vs CALASPARGASE PEGOL-MKNL